Bristol-Myers Squibb (BMY) Profit Margin History

Historical gross, operating and net quarterly profit margin for Bristol-Myers Squibb (BMY) over the last 10 years. The current net profit margin for Bristol-Myers Squibb as of August 17, 2017 is 22.66%.

Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $94.296B $19.427B
Bristol-Myers Squibb Company is a global leader in the research and development of innovative lifesaving and life-enhancing treatments for heart disease; high blood pressure; stroke; diabetes; cancer; HIV/AIDS and other infectious diseases; depression, schizophrenia and other mental disorders; pain; and other conditions.